Hilary Baldwin , M.D.

Dr. Mattingly is a biopharmaceutical executive who has served as a member of Tech Coast Angels. Previously, Dr. Mattingly served as the Chief Executive Officer of Trimeris, Inc., a biopharmaceutical company, from November 2007 until its merger with Synageva in November 2011. He also served on the Board of Directors of Trimeris, Inc. from November 2007 until November 2011. From 2005 to 2007, Dr. Mattingly was employed at Ambrx, Inc., a biopharmaceutical company, where he served as President and Chief Executive Officer. From 2003 to 2005, Dr. Mattingly served as Executive Vice President and Chief Operating Officer of CancerVax Corporation, a biotechnology company. From 1996 to 2003, he provided senior leadership in various management positions at Agouron

Xycrobe Therapeutics Advisors​

Dr. Miller has worked for more than 30 years in the medical device and pharmaceutical/biotech industries, resulting in product approvals across a broad range of therapeutic areas (cardiovascular, infectious disease, neurology and pulmonary) generating over $1 billion in annual revenues. Dr. Miller has extensive experience in leading cross-functional teams on clinical development, regulatory submission preparation, and global product launches for start-up, mid-sized and Fortune 500 firms. These include Ulthera, Inc., Abbott Laboratories, Dow Chemical, Dey Labs, DSI International and ImaRx Therapeutics.  Dr. Miller earned his doctoral degree in pharmacology from Vanderbilt University, a Master of Science degree in chemistry from Purdue University and a Bachelor of Arts degree in

Channel. She is also a frequent guest expert for Good Morning America, GMA Health, and The Mike and Juliet Show, and has had several appearances on CNN, the Today Show, iVillage, The Tyra Banks Show and many other television and internet events, as well as features in major women’s magazines including In Style, Allure, Vogue, Glamour, W, and Redbook.

Doris Day, MD is a board certified dermatologist who specializes in laser, cosmetic and surgical dermatology on the Upper East Side in New York City.  Dr. Day is affiliated with Lenox Hill Hospital in New York City and is a clinical assistant professor of dermatology at the New York University Langone Medical Center where she was presented with the award for Dedication and Excellence in the Teaching of Dermatology.

Dr. Day is a highly-respected and sought-after media personality in the area of dermatology. She has written and spoken extensively in this area including hour-long documentaries on cosmetic procedures for the Discovery

chemistry from Valparaiso University.  Dr. Miller currently acts as a consultant for medical device and pharmaceutical/biotech companies in the areas of clinical, medical and regulatory affairs.

Randy Miller, Ph.D.

Martin Mattingly, PharmD

Hilary E. Baldwin, MD is the Medical Director of the Acne Cure Alliance. She is a practicing Dermatologist (Skin Specialist) in Brooklyn, NY. Dr. Baldwin graduated from Boston University School of Medicine in 1984 and has been in practice for 31 years. She completed a residency at Yale University School of Medicine. She currently practices at Downstate Pathology Group and is affiliated with Kings County Hospital Center and SUNY Downstate Medical Center University Hospital of Brooklyn. Dr. Baldwin accepts multiple insurance plans including TRICARE, HealthFirst NY and Multiplan. Dr. Baldwin is board certified in Dermatology. Dr. Baldwin also practices at Dermatology Office in Brooklyn, NY.

Doris Day, M.D.

Pharmaceuticals, Inc. and Pfizer, Inc., including serving as General Manager of the Agouron HIV division, Vice President, Product Development Group at Pfizer and Vice President, Global Marketing Planning at Pfizer. Dr. Mattingly holds a Doctor of Pharmacy degree from the University of Kentucky.